Do SGLT2 inhibitors reduce left ventricular mass as assessed by cMRI?
SGLT2 inhibitors are associated with a reduction in left ventricular mass on cardiac MRI, providing imaging-based evidence for their role in favorable cardiac remodeling.
Sodium-glucose cotransporter-2 inhibitors treatment was associated with a reduction in left ventricular mass as assessed by cMRI.
Dhingra et al. (Fri,) studied this question.